Jelle A. Spoorendonk

Statistics

Publications

Citations

H-Index

Active since

2011

Affiliations

Jelle A. Spoorendonk is an author at Centre for Human Drug Research specializing in receptor-ligand interactions, receptor-mediated signaling, and pharmacy.

ORCID

Publications per year

2011–2022

Publications

A Novel Nonribose Agonist, LUF5834, Engages Residues That Are Distinct from Those of Adenosine-Like Ligands to Activate the Adenosine A2a Receptor

J. Robert Lane, Carmen Klein Herenbrink, Gerard J. P. van Westen et al. · Molecular Pharmacology · 2011 · 42 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Cost and Clinical Benefits Associated with Oncotype DX® Test in Patients with Early-Stage HR+/HER2- Node-Negative Breast Cancer in the Netherlands

Felix E. de Jongh, Reva Efe, K Herrmann et al. · International Journal of Breast Cancer · 2022 · 16 citations · Full text

Pharmacy, Oncology, Pharmacoeconomics +16

1–2 of 2